Effect of pirfenidone on plasma markers of collagen turnover in patients with heart failure, preserved left ventricular ejection fraction and myocardial fibrosis.
Saved in:
| Title: | Effect of pirfenidone on plasma markers of collagen turnover in patients with heart failure, preserved left ventricular ejection fraction and myocardial fibrosis. |
|---|---|
| Authors: | Black N; BHF Manchester Centre for Heart and Lung Magnetic Resonance Research, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester, M13 9LT, UK, Manchester, UK.; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK., Lewis G; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Soltani F; BHF Manchester Centre for Heart and Lung Magnetic Resonance Research, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester, M13 9LT, UK, Manchester, UK.; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK., Dodd S; Department of Health Data Science, Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK., Schelbert EB; Allina Health Minneapolis Heart Institute, Allina Health, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA., Ravassa S; Program of Cardiovascular Research, Centro de Investigación Médica Aplicada, Universidad de Navarra, and IdiSNA and CIBERCV, Pamplona, Spain., López B; Program of Cardiovascular Research, Centro de Investigación Médica Aplicada, Universidad de Navarra, and IdiSNA and CIBERCV, Pamplona, Spain., González A; Program of Cardiovascular Research, Centro de Investigación Médica Aplicada, Universidad de Navarra, and IdiSNA and CIBERCV, Pamplona, Spain.; Department of Cardiology and Cardiac Surgery, Clínica Universidad de Navarra, Pamplona, Spain., Cleland JG; British Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Miller CA; BHF Manchester Centre for Heart and Lung Magnetic Resonance Research, Manchester University NHS Foundation Trust, Southmoor Road, Wythenshawe, Manchester, M13 9LT, UK, Manchester, UK christopher.miller@manchester.ac.uk.; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. |
| Source: | Open heart [Open Heart] 2026 Feb 10; Vol. 13 (1). Date of Electronic Publication: 2026 Feb 10. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101631219 Publication Model: Electronic Cited Medium: Print ISSN: 2053-3624 (Print) Linking ISSN: 20533624 NLM ISO Abbreviation: Open Heart Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
